Human Papillomavirus: Vaccination

Department of Health written question – answered on 30th June 2015.

Alert me about debates like this

Photo of Mike Freer Mike Freer Conservative, Finchley and Golders Green

To ask the Secretary of State for Health, what assessment he has made of the potential benefits of trialling HPV vaccinations for men who have sex with men in a small number of GUM clinics as part of a wider cost-effectiveness evaluation.

Photo of Jane Ellison Jane Ellison The Parliamentary Under-Secretary of State for Health

It is the role of the independent expert body, the Joint Committee on Vaccination and Immunisation (JCVI), to provide advice on vaccination programmes following consideration of evidence, including on the cost effectiveness of immunisation strategies.

In June 2015 the JCVI human papillomavirus (HPV) subcommittee met to consider a revised impact and cost effectiveness assessment by Public Health England on a targeted HPV vaccination programme for men who have sex with men (MSM). This revised consideration took into account comments from an independent peer review and a stakeholder consultation. The results of a small pilot study (unpublished) that was conducted in North West London on the feasibility and acceptability of a vaccination programme for MSM were also used to inform the revised assessment.

The JCVI is due to consider the results of the HPV Subcommittee meeting at its October 2015 meeting, when it is anticipated that the Committee will be in a position to finalise its advice to the Department on an HPV vaccination programme for MSM.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.